Adagene/ US0053291078 /
| 2024-05-03 4:01:40 PM | Chg. +0.03 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 2.49USD | +1.22% | 100 Turnover: 249 |
-Bid Size: - | -Ask Size: - | 2.49 | 2.49 |
GlobeNewswire
03-07
Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board
GlobeNewswire
02-09
Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 S...
GlobeNewswire
01-16
Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® A...
GlobeNewswire
01-04
Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combinatio...
GlobeNewswire
2023-11-03
Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEb...
GlobeNewswire
2023-10-12
Adagene Announces Poster Presentation on Optimal Dose Selection for Masked Anti-CTLA-4 SAFEbody® ADG...
GlobeNewswire
2023-08-31
Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
GlobeNewswire
2022-03-08
Adagene Announces Four Poster Presentations on Robust Preclinical Pipeline of Antibody-Based Therape...
GlobeNewswire
2022-03-02
Adagene Announces SAFEbody® Multi-Target Collaboration with Sanofi for Novel Masked Immuno-Oncology ...
GlobeNewswire
2022-02-08
Adagene to Participate in the SVB Leerink 11th Annual Global Healthcare Conference
GlobeNewswire
2022-02-02
Adagene Announces Board and Management Appointments to Support Pipeline Growth
GlobeNewswire
2022-01-27
Adagene Announces First Patient Dosed with Novel, Proprietary Combination of Anti-CD137 Agonist, ADG...
GlobeNewswire
2022-01-19
Adagene Expands Scientific and Strategic Advisory Board with Appointment of David Gandara, M.D.
GlobeNewswire
2022-01-13
Adagene Announces First Patients with Advanced Non-Small Cell Lung Cancer Dosed in Phase 1b/2 Clinic...
GlobeNewswire
2021-12-22
Adagene Achieves Key Milestone in Collaboration with Exelixis for SAFEbody® Novel Masked Antibody-Dr...
GlobeNewswire
2021-12-13
Adagene Presents Preclinical Data Showcasing Best-in-Class Profiles for ADG153, an Anti-CD47 SAFEbod...
GlobeNewswire
2021-12-06
Adagene Presents Clinical Data Demonstrating Strong Safety and Early Signals of Efficacy in Cold Tum...
GlobeNewswire
2021-12-06
Adagene Presents Clinical Data Demonstrating Strong Safety and Early Signals of Efficacy in Treatmen...
GlobeNewswire
2021-11-29
Adagene Announces FDA Clearance of IND for Phase 1b/2 Trial of Anti-CTLA-4 Monoclonal Antibody ADG11...
GlobeNewswire
2021-11-22
Adagene Announces Poster Presentations of Clinical Data for Two Novel Antibody Programs at ESMO Immu...
GlobeNewswire
2021-11-09
Adagene to Participate in Upcoming Investor & Industry Conferences in November
